The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Will Be The Estimated Market Size Of The Psoriatic Arthritis Treatment Market By 2030?
The psoriatic arthritis treatment market has experienced robust expansion in recent years. It is projected to grow from $13.17 billion in 2025 to $14.36 billion in 2026, at a compound annual growth rate (CAGR) of 9.0%. The historical growth of this market can be attributed to several factors including the limited availability of advanced therapies, a reliance on conventional NSAIDs and DMARDs, the increasing prevalence of psoriatic arthritis, growing patient awareness, and the expansion of hospital and retail pharmacy infrastructure.
The psoriatic arthritis treatment market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $20.62 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.5%. Factors contributing to this anticipated growth include advancements in interleukin inhibitors and JAK inhibitors, the growing use of biologics, the emergence of personalized medicine strategies, increased utilization of telemedicine for managing chronic conditions, and enhanced government and insurance assistance for psoriatic arthritis care. Key trends expected during this period encompass the escalating uptake of biologics and targeted synthetic DMARDs, heightened recognition of early diagnosis and effective management of psoriatic arthritis, the evolution of tailored treatment methods for both joint and skin manifestations, the expansion of hospital and specialized pharmacy distribution networks, and the incorporation of telemedicine and remote monitoring for individuals with psoriatic arthritis.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3458&type=smp
Which Growth Drivers Are Expected To Support The Psoriatic Arthritis Treatment Market Forward?
The rise in healthcare expenditure is expected to propel the growth of the psoriatic arthritis treatment market going forward. Healthcare spending, also referred to as healthcare expenditure, represents the financial resources allocated to support the provision of healthcare services, products, and programs within a specific country, region, or healthcare system. This funding supports the diagnostic process by covering medical appointments, laboratory tests, and imaging studies. Patients with PsA often undergo a comprehensive evaluation to confirm the diagnosis, determine the extent of joint involvement, and assess any associated comorbidities. For instance, in December 2024, according to the Centers for Medicare & Medicaid Services, a US-based agency responsible for administering the Medicare and Medicaid programs, in 2023, U.S. health care expenditures increased by 7.5%, climbing to $4.9 trillion, or roughly $14,570 for each individual. Therefore, the increase in healthcare spending is driving the growth of the psoriatic arthritis treatment market.
What Segment Types Are Included In The Psoriatic Arthritis Treatment Market Analysis?
The psoriatic arthritis treatment market covered in this report is segmented –
1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDS), Disease-Modifying Anti-Rheumatic Drugs (DMARDS), Biologics, Other Drug Classes
2) By Route Of Administration: Oral, Parenteral, Topical
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Traditional NSAIDs, COX-2 Inhibitors
2) By Disease-Modifying Anti-Rheumatic Drugs (DMARDs): Conventional DMARDs, Targeted Synthetic DMARDs
3) By Biologics: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Other Biologics
4) By Other Drug Classes: Corticosteroids, Topical Treatments, Janus Kinase (JAK) Inhibitors
Which Trends Are Guiding The Development Of The Psoriatic Arthritis Treatment Market?
Major companies in the psoriatic arthritis treatment market are securing approvals for new drugs like Cosentyx to enhance their market profitability. Cosentyx is a medication utilized for treating autoimmune conditions such as non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and enthesitis-related arthritis. For example, in October 2023, Novartis, a pharmaceutical company from Switzerland, announced that its new drug Cosentyx had received approval from the Food and Drug Administration. Cosentyx acts as a human interleukin-17A antagonist, preventing the activation of the IL-17A protein, which helps reduce potential patient side effects like edema, discomfort, and skin rashes. Cosentyx has demonstrated effectiveness in addressing psoriatic arthritis symptoms and can begin working in as little as three weeks. It alleviates various psoriatic arthritis symptoms, including joint pain and tenderness, back discomfort, and skin problems.
Which Organizations Are Involved In The Psoriatic Arthritis Treatment Market?
Major companies operating in the psoriatic arthritis treatment market are AbbVie Inc., Amgen Astellas BioPharma K.K., Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Celgene Corporation, Novartis International AG, Eli Lilly and Company, Pfizer Inc., Merck & Co. Inc., AstraZeneca plc, Sanofi SA, Otsuka Pharmaceutical Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Bayer AG, Eisai Inc., Janssen Pharmaceuticals Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Chugai Pharmaceutical Co. Ltd., Kyowa Kirin Co. Ltd.
Access The Complete Psoriatic Arthritis Treatment Market Report:
Which Region Holds The Largest Share In The Psoriatic Arthritis Treatment Market?
North America was the largest region in the psoriatic arthritis treatment market in 2025. The regions covered in the psoriatic arthritis treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Psoriatic Arthritis Treatment Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=3458&type=smp
Browse Through More Reports Similar to the Global Psoriatic Arthritis Treatment Market 2026, By The Business Research Company
Musculoskeletal Disorder Drugs Market Report 2026
Microbiome Therapeutics Market Report 2026
https://www.thebusinessresearchcompany.com/report/microbiome-therapeutics-global-market-report
Orthobiologics Devices And Equipment Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model